208 related articles for article (PubMed ID: 34387888)
1. Pharmacologic activation of hepatic farnesoid X receptor prevents parenteral nutrition-associated cholestasis in mice.
El Kasmi KC; Ghosh S; Anderson AL; Devereaux MW; Balasubramaniyan N; D'Alessandro A; Orlicky DJ; Suchy FJ; Shearn CT; Sokol RJ
Hepatology; 2022 Feb; 75(2):252-265. PubMed ID: 34387888
[TBL] [Abstract][Full Text] [Related]
2. NF-κB Regulation of LRH-1 and ABCG5/8 Potentiates Phytosterol Role in the Pathogenesis of Parenteral Nutrition-Associated Cholestasis.
Ghosh S; Devereaux MW; Anderson AL; Gehrke S; Reisz JA; D'Alessandro A; Orlicky DJ; Lovell M; El Kasmi KC; Shearn CT; Sokol RJ
Hepatology; 2021 Dec; 74(6):3284-3300. PubMed ID: 34310734
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis.
El Kasmi KC; Vue PM; Anderson AL; Devereaux MW; Ghosh S; Balasubramaniyan N; Fillon SA; Dahrenmoeller C; Allawzi A; Woods C; McKenna S; Wright CJ; Johnson L; D'Alessandro A; Reisz JA; Nozik-Grayck E; Suchy FJ; Sokol RJ
Nat Commun; 2018 Apr; 9(1):1393. PubMed ID: 29643332
[TBL] [Abstract][Full Text] [Related]
4. LRH-1 agonist DLPC through STAT6 promotes macrophage polarization and prevents parenteral nutrition-associated cholestasis in mice.
Ghosh S; Devereaux MW; Liu C; Sokol RJ
Hepatology; 2024 May; 79(5):986-1004. PubMed ID: 37976384
[TBL] [Abstract][Full Text] [Related]
5. Interrupting tumor necrosis factor-alpha signaling prevents parenteral nutrition-associated cholestasis in mice.
El Kasmi KC; Anderson AL; Devereaux MW; Balasubramaniyan N; Suchy FJ; Orlicky DJ; Shearn CT; Sokol RJ
JPEN J Parenter Enteral Nutr; 2022 Jul; 46(5):1096-1106. PubMed ID: 34664730
[TBL] [Abstract][Full Text] [Related]
6. Liver Inflammation Relates to Decreased Canalicular Bile Transporter Expression in Pediatric Onset Intestinal Failure.
Mutanen A; Lohi J; Heikkilä P; Jalanko H; Pakarinen MP
Ann Surg; 2018 Aug; 268(2):332-339. PubMed ID: 28234635
[TBL] [Abstract][Full Text] [Related]
7. Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis.
Ghosh S; Devereaux MW; Anderson AL; El Kasmi KC; Sokol RJ
Hepatol Commun; 2023 Mar; 7(3):e0056. PubMed ID: 36848082
[TBL] [Abstract][Full Text] [Related]
8. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
[TBL] [Abstract][Full Text] [Related]
10. Dehydrodiconiferyl alcohol, a lignan from Herpetospermum pedunculosum, alleviates cholestasis by activating pathways associated with the farnesoid X receptor.
Wei X; Ma Y; Dong Z; Wang G; Lan X; Liao Z; Chen M
Phytomedicine; 2021 Jan; 80():153378. PubMed ID: 33113499
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
[TBL] [Abstract][Full Text] [Related]
12. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
13. Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice.
Wang J; Einarsson C; Murphy C; Parini P; Björkhem I; Gåfvels M; Eggertsen G
J Lipid Res; 2006 Feb; 47(2):421-30. PubMed ID: 16264196
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
15. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
Verhaag EM; Buist-Homan M; Koehorst M; Groen AK; Moshage H; Faber KN
PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211
[TBL] [Abstract][Full Text] [Related]
16. Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences.
Molusky MM; Hsieh J; Lee SX; Ramakrishnan R; Tascau L; Haeusler RA; Accili D; Tall AR
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1493-1503. PubMed ID: 29853564
[TBL] [Abstract][Full Text] [Related]
17. Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity.
Yu J; Lo JL; Huang L; Zhao A; Metzger E; Adams A; Meinke PT; Wright SD; Cui J
J Biol Chem; 2002 Aug; 277(35):31441-7. PubMed ID: 12052824
[TBL] [Abstract][Full Text] [Related]
18. Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition.
Shearn CT; Anderson AL; Devereaux MW; El Kasmi KC; Orlicky DJ; Sokol RJ
PLoS One; 2023; 18(8):e0290385. PubMed ID: 37647292
[TBL] [Abstract][Full Text] [Related]
19. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
[TBL] [Abstract][Full Text] [Related]
20. Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters.
Sissung TM; Huang PA; Hauke RJ; McCrea EM; Peer CJ; Barbier RH; Strope JD; Ley AM; Zhang M; Hong JA; Venzon D; Jackson JP; Brouwer KR; Grohar P; Glod J; Widemann BC; Heller T; Schrump DS; Figg WD
Mol Pharmacol; 2019 Aug; 96(2):158-167. PubMed ID: 31175181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
